Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer

Clinical trial NCT04058964 · WITHDRAWN

Trial details

NCT number: NCT04058964
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2020-02-01
Primary completion: 2022-10-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.